Jacob P Laubach

Phase transitions in human IgG solutions.

Ying Wang, N. Munshi, J. Laubach, 2013, The Journal of chemical physics.

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.

Neeraj Gupta, Eileen Liao, Parameswaran Hari, 2014, The Lancet. Oncology.